Stay updated on Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check13 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe history list now shows a new revision label v3.7.0, replacing the prior v3.6.6. This reflects a new version of the page's record history interface.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page history shows a release version update, replacing v3.6.5 with v3.6.6 in the footer/release notes.SummaryDifference0.0%

- Check76 days agoChange DetectedA new revision v3.6.5 was added to the study record history, replacing the previous v3.6.4, indicating a metadata update to the record's version history.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page’s revision line in the history was updated from v3.6.3 to v3.6.4, indicating a new release entry has been recorded for the study history. This change reflects an internal version update rather than a modification to study content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.